Rosalind Kalb from the National Multiple Sclerosis Society: The Future of Multiple Sclerosis Care and Patient Support Groups

New medications are constantly being developed and approved for the treatment of multiple sclerosis. How those treatments are used and what the future holds for the disease remains to be seen.

In just the past 10-15 years Rosalind Kalb, PhD, from the National Multiple Sclerosis Society said she has seen the treatment of the condition make great strides. Even as progress is made on the clinical front Kalb said it is important to consider the entire picture of patient care.